Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
Clinical trial NCT05501886 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05501886
- Sponsor
- Celcuity Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2026-06-30
- Enrollment
- 701
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.